Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

An open-label multicenter study on the efficacy of continuous oral dosing of RO5185426 on tumour response in previously treated patients with metastatic melanoma
vemurafenib
NP22657 (BRIM2)
NCT00949702
malignant melanoma of skin
Phase 2
 
January 2014

Powered by ideaPoint, Inc.